🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 21 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 19/09/1986 | 5,20 | 5,22 | 5,17 | 5,17 | -1,51% | 1,02% | 10.473.293 |
| 18/09/1986 | 5,20 | 5,29 | 5,18 | 5,25 | +1,02% | 2,04% | 7.466.371 |
| 17/09/1986 | 5,30 | 5,31 | 5,18 | 5,20 | -1,75% | 2,50% | 10.744.934 |
| 16/09/1986 | 5,23 | 5,29 | 5,17 | 5,29 | +0,50% | 2,28% | 8.351.093 |
| 15/09/1986 | 5,23 | 5,31 | 5,20 | 5,26 | +0,89% | 2,16% | 8.622.734 |
| 12/09/1986 | 5,30 | 5,33 | 5,17 | 5,22 | -1,38% | 3,00% | 18.024.552 |
| 11/09/1986 | 5,53 | 5,53 | 5,25 | 5,29 | -4,66% | 5,15% | 13.042.570 |
| 10/09/1986 | 5,53 | 5,56 | 5,47 | 5,55 | +0,36% | 1,68% | 6.085.526 |
| 09/09/1986 | 5,63 | 5,67 | 5,50 | 5,53 | -0,72% | 3,06% | 10.128.082 |
| 08/09/1986 | 5,73 | 5,73 | 5,54 | 5,57 | -4,87% | 3,35% | 18.864.000 |
| 05/09/1986 | 5,98 | 6,00 | 5,80 | 5,85 | -2,86% | 3,33% | 9.424.454 |
| 04/09/1986 | 5,95 | 6,08 | 5,91 | 6,02 | +1,45% | 2,90% | 9.814.939 |
| 03/09/1986 | 5,88 | 5,99 | 5,86 | 5,94 | +1,01% | 2,14% | 7.368.278 |
| 02/09/1986 | 6,12 | 6,13 | 5,84 | 5,88 | -4,11% | 4,65% | 7.709.717 |
| 29/08/1986 | 6,04 | 6,14 | 6,03 | 6,13 | +1,65% | 1,75% | 4.740.523 |
| 28/08/1986 | 5,93 | 6,03 | 5,90 | 6,03 | +1,79% | 2,23% | 4.666.954 |
| 27/08/1986 | 5,95 | 5,99 | 5,89 | 5,92 | -0,78% | 1,67% | 4.814.093 |
| 26/08/1986 | 5,88 | 5,99 | 5,87 | 5,97 | +1,24% | 2,03% | 6.081.754 |
| 25/08/1986 | 6,01 | 6,01 | 5,87 | 5,90 | -1,87% | 2,31% | 5.187.600 |
| 22/08/1986 | 5,99 | 6,06 | 5,99 | 6,01 | +0,22% | 1,11% | 3.802.982 |
| 21/08/1986 | 6,04 | 6,06 | 5,95 | 6,00 | -0,44% | 1,75% | 5.615.813 |
| 20/08/1986 | 6,11 | 6,12 | 6,02 | 6,02 | -1,62% | 1,63% | 5.670.518 |
| 19/08/1986 | 6,13 | 6,16 | 6,11 | 6,12 | -0,64% | 0,86% | 4.440.586 |
| 18/08/1986 | 6,13 | 6,19 | 6,10 | 6,16 | +0,87% | 1,51% | 7.356.960 |
| 15/08/1986 | 6,06 | 6,11 | 6,00 | 6,11 | +1,21% | 1,75% | 9.530.093 |
| 14/08/1986 | 5,94 | 6,08 | 5,94 | 6,04 | +1,45% | 2,23% | 7.155.115 |
| 13/08/1986 | 5,86 | 6,02 | 5,84 | 5,95 | +1,93% | 3,06% | 8.094.542 |
| 12/08/1986 | 5,80 | 5,85 | 5,76 | 5,84 | +0,80% | 1,49% | 7.368.278 |
| 11/08/1986 | 5,69 | 5,80 | 5,67 | 5,79 | +2,34% | 2,21% | 7.666.330 |
| 08/08/1986 | 5,73 | 5,75 | 5,66 | 5,66 | -1,27% | 1,51% | 2.574.936 |